Id Said, Badr
Chen, Hanbo
Jerzak, Katarzyna J.
Warner, Ellen
Myrehaug, Sten
Tseng, Chia-Lin
Detsky, Jay
Husain, Zain
Sahgal, Arjun
Soliman, Hany
Article History
Received: 6 May 2022
Accepted: 1 June 2022
First Online: 17 June 2022
Declarations
:
: BI (none), HC (none), KJJ (advisor: Amgen, AzstraZeneca, Apo Biologix, Eli Lily, Esai, Genomic Health, Knight Therapeutics,Merck. Myriad Genetics Inc, Noveratis, Purdue Pharma, Pfizer, Roche, Seagen; grant: Aztra Zeneca, Eli Lilly, Seagen), EW (none), SM (none), CLT (advisor: Sanofi, Elekta MR-linac consortium), JD (none), ZH (none), AJ (advisor: Gamma Knife Icon, honoraria: Astra Zeneca, BrainLAB, Elekta AB; grant: Elekta, BrainLAB, Varian), HS (none)
: This study received REB approval prior to study initiation.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.